Greenberger P A, Patterson R
Department of Medicine, Northwestern University Medical School, Chicago, IL 60611.
J Allergy Clin Immunol. 1991 Apr;87(4):867-72. doi: 10.1016/0091-6749(91)90135-b.
The use of lower osmolality radiocontrast media (RCM) has been associated with satisfactory radiographic opacification and a reduced incidence of severe reactions. The higher cost without clearly established benefit of these media have limited their use. This investigation assessed the incidence of immediate generalized reactions (IGRs) to repeated RCM IGRs in pretreated high-risk patients who received iopamidol or iohexol during 200 procedures (181 intravascular). All patients had experienced a previous IGR to a conventional RCM. Pretreatment consisted of prednisone, 50 mg, 13, 7, and 1 hour before the procedure and diphenhydramine, 50 mg, 1 hour before the procedure in 140 intravascular infusions. Ephedrine, 25 mg, 1 hour before the infusion was added to prednisone-diphenhydramine in 41 cases. Only one (0.7%) urticarial reaction occurred in 141 procedures with prednisone-diphenhydramine. No repeated IGR occurred with the three-drug regimen. The reaction rate after pretreatment with prednisone-diphenhydramine or prednisone-diphenhydramine-ephedrine and use of conventional contrast media during 800 intravascular procedures was 9.1%, and with pretreatment and lower osmolality contrast media in 181 intravascular infusions, it was 0.5% (chi 2 = 14.35; p less than 0.001). Lower osmolality contrast media should be the contrast media of choice for patients with a prior IGR to conventional contrast media. In addition, patients should receive prednisone-diphenhydramine-ephedrine or prednisone-diphenhydramine prophylaxis.
使用低渗性造影剂(RCM)已被证明能带来令人满意的影像学显影效果,并降低严重反应的发生率。然而,这些造影剂成本较高且益处并不明确,限制了它们的使用。本研究评估了在200例操作(181例血管内操作)中,接受碘帕醇或碘海醇的预处理高危患者重复发生RCM所致即刻全身反应(IGR)的发生率。所有患者既往均对传统RCM发生过IGR。预处理方案为:在操作前13、7和1小时分别给予泼尼松50mg,在140例血管内输注中,操作前1小时给予苯海拉明50mg。在41例中,在泼尼松 - 苯海拉明基础上,输注前1小时添加麻黄碱25mg。在使用泼尼松 - 苯海拉明的141例操作中,仅发生1例(0.7%)荨麻疹反应。三联药物方案未出现重复IGR。在800例血管内操作中,使用泼尼松 - 苯海拉明或泼尼松 - 苯海拉明 - 麻黄碱预处理并使用传统造影剂后的反应率为9.1%,而在181例血管内输注中,使用预处理和低渗性造影剂后的反应率为0.5%(χ² = 14.35;p < 0.001)。对于既往对传统造影剂发生过IGR的患者,低渗性造影剂应作为首选造影剂。此外,患者应接受泼尼松 - 苯海拉明 - 麻黄碱或泼尼松 - 苯海拉明预防治疗。